Isfahan University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Efficacy and Safety of a Proposed Omalizumab Biosimilar Compared to the Reference Product in the Management of Uncontrolled Moderate-To-Severe Allergic Asthma: A Multicenter, Phase Iii, Randomized, Double-Blind, Equivalency Clinical Trial
Nazila Poostiyan
Nazila Poostiyan

Assistant Professor of Dermatology

Department of Dermatology, School of Medicine

Skin Diseases and Leishmaniasis Research Center

Isfahan University of Medical Sciences

All Documents